Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
1-Methyl-d-Tryptophan in Treating Patients With Relapsed or Refractory Solid Tumors
| Conditions: | Cancer |
| Start Date: | August 1, 2008 |
| Phase: | Phase I |
| Status: | Recruiting |
| NCT ID: | NCT00788086 |
| Study Type: | Interventional |
| Intervention: | Drug: 1-methyl-d-tryptophan/Other: flow cytometry/Other: fluorescence activated cell sorting/Other: high performance liquid chromatography/Other: immunohistochemistry staining method/Other: laboratory biomarker analysis/Other: pharmacological study |
| Study Design: | Treatment/Non-Randomized/Open Label |
| Results: | No Results Available |
| Sponsors: | Vanderbilt-Ingram Cancer Center/National Cancer Institute (NCI) |
| Ages: | Adult/Senior |
| Enrollment: | 30 |
| Funded By: | OTHER/NIH |
| First Received: | November 7, 2008 |
| End Date: | January 1, 1900 |
| Last Updated: | August 11, 2009 |
| Last Verified: | October 1, 2008 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
